| Product NDC: | 15054-0211 |
| Proprietary Name: | APOKYN |
| Non Proprietary Name: | APOMORPHINE HYDROCHLORIDE |
| Active Ingredient(s): | 30 mg/3mL & nbsp; APOMORPHINE HYDROCHLORIDE |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 15054-0211 |
| Labeler Name: | Tercica, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021264 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040702 |
| Package NDC: | 15054-0211-5 |
| Package Description: | 5 CARTRIDGE in 1 CARTON (15054-0211-5) > 3 mL in 1 CARTRIDGE (15054-0211-1) |
| NDC Code | 15054-0211-5 |
| Proprietary Name | APOKYN |
| Package Description | 5 CARTRIDGE in 1 CARTON (15054-0211-5) > 3 mL in 1 CARTRIDGE (15054-0211-1) |
| Product NDC | 15054-0211 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | APOMORPHINE HYDROCHLORIDE |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20040702 |
| Marketing Category Name | NDA |
| Labeler Name | Tercica, Inc. |
| Substance Name | APOMORPHINE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/3mL |
| Pharmaceutical Classes | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |